Natixis Vaccinex, Inc. Transaction History

Natixis

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.92 - $1.94 $29,343 - $61,876	-31,895 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.11 - $2.81 $67,298 - $89,624	31,895 New	31,895 $69,000
Q2 2021 Aug 13, 2021	SELL	$2.01 - $3.0 $35,968 - $53,685	-17,895 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$2.09 - $5.11 $37,400 - $91,443	17,895 New	17,895 $53,000

426K

Ticker VCNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,664,100
Market Cap $287M
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.